
INSIGHT MOLECULAR DIAGNOSTIC
IMDX · NASDAQ
Updated at 2026-10-13 15:06:24
- Today's High
- $3.21
- Today’s Low
- $3.05
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.35
- Previous Close
- $3.17
- Volume
- 219.51K
- Market Cap
- $103.73M
- P/E Ratio
- --
- EPS
- $-1.48
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DIAGNOSTICS & RESEARCH
- Headquarters
- 2 INTERNATIONAL PLAZA DR., NASHVILLE, TN, UNITED STATES, 37217
- Country
- US
- Listing Date
- 2015-12-30
- Fiscal Year End
- December
- Shares Outstanding
- 32.29M
- CIK
- 0001642380
- Website
- imdxinc.com
OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
Financial Metrics
Revenue
2026-06-30
$239K
2026-03-31
$32K
2025-12-31
$1.13M
2025-09-30
$260K
Operating Expenses
2026-06-30
$11.55M
2026-03-31
$9.72M
2025-12-31
$10.44M
2025-09-30
$11.18M
Net Income
2026-06-30
-$11.26M
2026-03-31
-$4.29M
2025-12-31
-$22.95M
2025-09-30
-$10.85M
Net Profit Margin
2026-06-30
-4.71K%
2026-03-31
-13.4K%
2025-12-31
-2.01K%
2025-09-30
-4.17K%
Earnings Per Share
2026-06-30
$-0.23
2026-03-31
$-0.12
2025-12-31
$-0.72
2025-09-30
$-0.23
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$10.57M
2026-03-31
-$3.63M
2025-12-31
-$22.36M
2025-09-30
-$10.24M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $239K | $32K | $1.13M | $260K |
| Operating Expenses | $11.55M | $9.72M | $10.44M | $11.18M |
| Net Income | -$11.26M | -$4.29M | -$22.95M | -$10.85M |
| Net Profit Margin | -4.71K% | -13.4K% | -2.01K% | -4.17K% |
| Earnings Per Share | $-0.23 | $-0.12 | $-0.72 | $-0.23 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$10.57M | -$3.63M | -$22.36M | -$10.24M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.